Literature DB >> 25109821

Expression and significance of Pin1, β-catenin and cyclin D1 in hepatocellular carcinoma.

Ran Ao1, Dao-Rong Zhang2, Ya-Qi Du1, Ying Wang1.   

Abstract

The aim of the present study was to examine the expression and significance of peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (Pin1), β‑catenin and cyclin D1 in hepatocellular carcinoma (HCC). A total of 24 samples of HCC and adjacent normal tissues were analyzed. The expression of Pin1, β‑catenin and cyclin D1 in HCC were detected using immunohistochemistry, western blot analysis, polymerase chain reaction and immunofluorescence. The expression of Pin1, β‑catenin and cyclin D1 in HCC tissues were significantly higher than that in adjacent tissues. Pin1 was not markedly expressed in the adjacent normal tissues, while expression in the cytoplasm and nucleus of HCC cells was high. However, β‑catenin and cyclin D1 only revealed a weak expression in the cytoplasm and nucleus of HCC cells. Immunoprecipitation analyses demonstrated two clear bands at 19 and 34 kDa, and a brown band at 55 kDa as expected. Immunofluorescence analysis of HCC cells indicated that Pin1 was present in the cytoplasm and nucleus, and β‑catenin and cyclin D1 were present in the nucleus. In conclusion, the present study indicated that Pin1, β‑catenin and cyclin D1 were highly expressed in HCC. Therefore, detection of the expression of Pin1, β‑catenin and cyclin D1 may be useful for the development of novel diagnostic and treatment strategies for HCC.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25109821     DOI: 10.3892/mmr.2014.2456

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  7 in total

1.  Ultrasound-Targeted Microbubble Destruction Mediated si-CyclinD1 Inhibits the Development of Hepatocellular Carcinoma via Suppression of PI3K/AKT Signaling Pathway.

Authors:  Wei Yan; Li Cheng; Dongmei Zhang
Journal:  Cancer Manag Res       Date:  2020-10-29       Impact factor: 3.989

2.  Eukaryotic translation initiation factor 3B accelerates the progression of esophageal squamous cell carcinoma by activating β-catenin signaling pathway.

Authors:  Fengkai Xu; Cheng-Zhi Xu; Jie Gu; Xiaoming Liu; Ronghua Liu; Enyu Huang; Yunfeng Yuan; Guangyin Zhao; Jiahao Jiang; Chen Xu; Yiwei Chu; Chunlai Lu; Di Ge
Journal:  Oncotarget       Date:  2016-07-12

Review 3.  Understanding the role of PIN1 in hepatocellular carcinoma.

Authors:  Chi-Wai Cheng; Ka-Wai Leong; Eric Tse
Journal:  World J Gastroenterol       Date:  2016-12-07       Impact factor: 5.742

4.  MicroRNA-140-5p inhibits hepatocellular carcinoma by directly targeting the unique isomerase Pin1 to block multiple cancer-driving pathways.

Authors:  Xingxue Yan; Zhendong Zhu; Shenmin Xu; Li-Nan Yang; Xin-Hua Liao; Min Zheng; Dayun Yang; Jichuang Wang; Dongmei Chen; Long Wang; Xiaolong Liu; Jingfeng Liu; Ruey-Hwa Chen; Xiao Zhen Zhou; Kun Ping Lu; Hekun Liu
Journal:  Sci Rep       Date:  2017-04-06       Impact factor: 4.379

5.  Chemical or genetic Pin1 inhibition exerts potent anticancer activity against hepatocellular carcinoma by blocking multiple cancer-driving pathways.

Authors:  Xin-Hua Liao; Arina Li Zhang; Min Zheng; Mei-Qing Li; Champ Peng Chen; Huijuan Xu; Qing-Song Chu; Dayun Yang; Wenxian Lu; Ting-Fen Tsai; Hekun Liu; Xiao Zhen Zhou; Kun Ping Lu
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

6.  Cell cycle regulation and anticancer drug discovery.

Authors:  Jingwen Bai; Yaochen Li; Guojun Zhang
Journal:  Cancer Biol Med       Date:  2017-11       Impact factor: 4.248

7.  Transcription factorIRX5 promotes hepatocellular carcinoma proliferation and inhibits apoptosis by regulating the p53 signalling pathway.

Authors:  Liying Zhu; Longguang Dai; Nenghong Yang; Mi Liu; Shuang Ma; Chengcheng Li; Jie Shen; Tao Lin; Dan Wang; Wei Pan; Xing Li
Journal:  Cell Biochem Funct       Date:  2020-03-09       Impact factor: 3.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.